SB 48
AN ACT REQUIRING MANUFACTURERS OF BRAND NAME PRESCRIPTION DRUGS TO PROVIDE SAMPLES OF SUCH DRUGS TO MANUFACTURERS OF GENERIC PRESCRIPTION DRUGS
CBIA opposed this bill, which passed 11- 5, with 3 legislators abstaining or absent.
Sen. (D-)
Rep. Tim Ackert (R-Coventry)
Rep. Raghib Allie-Brennan (D-Bethel)
Rep. Emil 'Buddy' Altobello (D-Meriden)
Rep. David Arconti Jr. (D-Danbury)
Sen. Dennis Bradley (D-Bridgeport)
Rep. Juan Candelaria (D-New Haven)
Rep. Vincent Candelora (R-North Branford)
Rep. Holly Cheeseman (R-Niantic)
Rep. Mike D'Agostino (D-Hamden)
Rep. Tony D'Amelio (R-)
Sen. John Fonfara (D-Hartford)
Rep. Bobby Gibson (D-Bloomfield)
Sen. John Kissel (R-Enfield)
Sen. Carlo Leone (D-Stamford)
Rep. Geoff Luxenberg (D-Manchester)
Sen. Douglas McCrory (D-Hartford)
Rep. Dave Rutigliano (R-Trumbull)
Sen. Kevin Witkos (R-Canton)
Stay Connected with CBIA News Digests
The latest news and information delivered directly to your inbox.